="研究事業"

  • このページを印刷する -

2022年7月 英文論文


NHO所属の著者を含む英文論文が239報出版されました。

内訳:本部(2)北海道がんセンター(8)北海道医療センター(3)函館病院(2)旭川医療センター(2)弘前病院(1)盛岡医療センター(1)仙台医療センター(5)仙台西多賀病院(4)あきた病院(1)水戸医療センター(3)霞ヶ浦医療センター(1)茨城東病院(1)高崎総合医療センター(3)東埼玉病院(2)千葉医療センター(1)千葉東病院(1)東京医療センター(8)災害医療センター(3)東京病院(2)村山医療センター(1)横浜医療センター(5)相模原病院(3)甲府病院(1)信州上田医療センター(1)金沢医療センター(3)長良医療センター(1)天竜病院(1)静岡医療センター(4)名古屋医療センター(15)豊橋医療センター(3)鈴鹿病院(1)三重中央医療センター(2)あわら病院(1)東近江総合医療センター(1)京都医療センター(13)宇多野病院(1)大阪医療センター(20)近畿中央呼吸器センター(7)大阪刀根山医療センター(7)大阪南医療センター(4)奈良医療センター(1)南和歌山医療センター(1)和歌山病院(1)松江医療センター(2)岡山医療センター(7)南岡山医療センター(1)呉医療センター(8)福山医療センター(1)東広島医療センター(2)山口宇部医療センター(2)岩国医療センター(3)東徳島医療センター(1)四国こどもとおとなの医療センター(2)四国がんセンター(11)愛媛医療センター(2)高知病院(2)小倉医療センター(1)九州がんセンター(10)九州医療センター(7)福岡病院(2)大牟田病院(2)福岡東医療センター(1)佐賀病院(1)嬉野医療センター(2)長崎病院(1)長崎医療センター(5)長崎川棚医療センター(2)熊本医療センター(3)宮崎東病院(1)鹿児島医療センター(3)沖縄病院(2)


本部

#環境科学
Tsuboi M, Sawano T, Ozaki A, Nonaka S, Kohayakawa Y, Kondo H, Tsubokura M
Comparison of mortality patterns after the Fukushima Daiichi Nuclear Power Plant radiation disaster and during the COVID-19 pandemic
J Radiol Prot. 2022 SEP 1;42(3)
Journal Impact Factor 2021: 1.559

#免疫学 #観察研究
Naito T, Tsuchida N, Kusunoki S, Kaneko Y, Tobita M, Hori S, Ito S
Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study
Expert Rev Vaccines. 2022 SEP 2;21(9):1319-1329.
Journal Impact Factor 2021: 5.683


北海道がんセンター

#医学 #研究 #実験
Chiba T, Ujiie H, Yaegashi Y, Umehara K, Takada S, Otaki K, Sako KI, Nakamaru Y, Meada T, Kudo K, Tasaki Y, Sato H
Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab
Biomed Rep. 2022 SEP;17(3)
Journal Impact Factor 2021: N/A

#腫瘍学 #第I相試験 #多施設共同研究
Kotani H, Masuda N, Yamashita T, Naito Y, Taira T, Inoue K, Takahashi M, Yonemori K, Toyoizumi S, Mori Y, Nagasawa T, Hori N, Iwata H
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
Breast Cancer. 2022 NOV;29(6):1088-1098.
Journal Impact Factor 2021: 3.307

#腫瘍学 #ランダム化比較試験
Yonemori K, Yunokawa M, Ushijima K, Sakata J, Shikama A, Minobe S, Usami T, Enomoto T, Takehara K, Hasegawa K, Yamagami W, Yamamoto K, Han SR, Dutta L, Orlowski R, Miura T, Makker V, Fujiwara K
Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775
Cancer Sci. 2022 OCT;113(10):3489-3497.
Journal Impact Factor 2021: 6.518

#腫瘍学 #第II相試験 #ランダム化比較試験
Tanaka K, Machida R, Kawai A, Nakayama R, Tsukushi S, Asanuma K, Matsumoto Y, Hiraga H, Hiraoka K, Watanuki M, Yonemoto T, Abe S, Katagiri H, Nishida Y, Nagano A, Suehara Y, Kawashima H, Kawano M, Morii T, Hatano H, Toguchida J, Okuma T, Takeyama M, Takenaka S, Akisue T, Furuta T, Emori M, Hiruma T, Outani H, Yamamoto T, Kataoka T, Fukuda H, Ozaki T, Iwamoto Y
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
Br J Cancer. 2022 NOV 1;127(8):1487-1496.
Journal Impact Factor 2021: 9.082

#腫瘍学 #第III相試験 #多施設共同研究 #ランダム化比較試験
Yamamoto Y, Iwata H, Taira N, Masuda N, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Saji S, Morita S, Toi M, Ohno S
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS)
Cancer Sci. 2022 SEP;113(9):3169-3179.
Journal Impact Factor 2021: 6.518

#腫瘍学 #第I相試験 #第II相試験
Ishizawa K, Yokoyama M, Kato H, Yamamoto K, Makita M, Ando K, Ueda Y, Tachikawa Y, Suehiro Y, Kurosawa M, Kameoka Y, Nagai H, Uoshima N, Ishikawa T, Hidaka M, Ito Y, Utsunomiya A, Fukushima K, Ogura M
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
Cancer Chemother Pharmacol. 2022 JUL;90(1):83-95.
Journal Impact Factor 2021: 3.288

#腫瘍学 #観察研究
Tsuruta T, Todo Y, Yamada R, Kuwahara K, Kurosu H, Minowa K, Minoura Y, Minobe S, Suzuki H, Kato H
Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study
Jpn J Clin Oncol. 2022 JUL 8;52(7):744-750.
Journal Impact Factor 2021: 2.925

#心臓 #循環器系
Mizukami Y, Maki R, Adachi H
Simple smoke ventilation method for uniportal video-assisted thoracoscopic surgery
Interact Cardiovasc Thorac Surg. 2022 JUL 9;35(2)
Journal Impact Factor 2021: 1.978


北海道医療センター

#臨床神経学
Yokote H, Miyazaki Y, Toru S, Nishida Y, Hattori T, Niino M, Sanjo N, Yokota T
High-efficacy therapy reduces subcortical grey matter volume loss in Japanese patients with relapse-onset multiple sclerosis: A 2-year cohort study
Mult Scler Relat Disord. 2022 NOV;67
Journal Impact Factor 2021: 4.808

#複合科学
Terano C, Hamada R, Tatsuno I, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Kaneko T, Ito S, Honda M, Ishikura K, Japanese Study Grp Renal Dis Child
Epidemiology of biopsy-proven Henoch-Schonlein purpura nephritis in children: A nationwide survey in Japan
PLoS One. 2022 JUL 8;17(7)
Journal Impact Factor 2021: 3.752

#医学 #一般医療 #内科学 #症例報告
Shioya N, Inoue N, Sato H, Iwahara M, Sato T, Tsukamoto Y, Naito Y, Hazama K, Shichinohe Y
Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
Clin Case Rep. 2022 JUL;10(7)
Journal Impact Factor 2021: N/A


函館病院

#医学 #一般医療 #内科学 #観察研究 #多施設共同研究
Kinoshita Y, Kato M, Sugizaki K, Ikeuchi S
Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study
Intern Med. 2023;62(4):495-502.
Journal Impact Factor 2021: 1.282

#内分泌学 #新陳代謝 #症例報告
Saishouji F, Maeda S, Hamada H, Kimura N, Tamanoi A, Nishida S, Sakaguchi M, Igata M, Yokoo K, Kawakami F, Araki E, Kondo T
Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report
BMC Endocr Disord. 2022 JUL 19;22(1)
Journal Impact Factor 2021: 3.263


旭川医療センター

#消化器病学 #肝臓学 #症例報告
Iwano H, Sato T, Ishii Y, Niki S, Sawaya R, Tamakawa S, Yamada M
Delayed perforation after cold snare polypectomy for small colonic polyps in a patient receiving oral corticosteroids
DEN Open. 2023 APR;3(1)

#臨床神経学
Kato H, Naito M, Saito T, Hideyama T, Suzuki Y, Kimura T, Kwak S, Aizawa H
Prolyl Isomerase Pin1 Expression in the Spinal Motor Neurons of Patients With Sporadic Amyotrophic Lateral Sclerosis
J Clin Neurol. 2022 JUL;18(4):463-469.
Journal Impact Factor 2021: 2.566


弘前病院

#公衆衛生学 #環境衛生学 #労働衛生学
Saito N, Kitazawa J, Horiuchi H, Yamamoto T, Kimura M, Inoue F, Matsui M, Minakawa S, Itoga M, Tsuchiya J, Suzuki S, Hisatsune J, Gu Y, Sugai M, Kayaba H
Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan
Antimicrob Resist Infect Control. 2022 JUL 23;11(1)
Journal Impact Factor 2021: 6.456


盛岡医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


仙台医療センター

#ウイルス学
Yajima T, Takahashi H, Kimura N, Sato K, Jingu D, Ubukata S, Shoji M, Watanabe H, Kodama EN, Nishimura H
Comparison of sputum specimens and nasopharyngeal swab specimens for diagnosis of acute human metapneumovirus-related lower respiratory tract infections in adults
J Clin Virol. 2022 SEP;154
Journal Impact Factor 2021: 14.481

#物質科学 #セラミックス
Sato A, Takahashi Y, Terakado N, Miyazaki T, Onoue N, Shinozaki T, Fujiwara T
Potential of afterglow zirconia as a sensitive biological temperature probe
Ceram Int. 2022 SEP 1;48(17):25587-25591.

#微生物学
Suwa R, Kume Y, Kawase M, Chishiki M, Ono T, Norito S, Sato K, Okamoto M, Kumaki S, Nagai Y, Hosoya M, Takeda M, Nishimura H, Hashimoto K, Shirato K
Practical Validation of United States Centers for Disease Control and Prevention Assays for the Detection of Human Respiratory Syncytial Virus in Pediatric Inpatients in Japan
Pathogens. 2022 JUL;11(7)
Journal Impact Factor 2021: 4.531

#臨床神経学
Ishida T, Inoue T, Niizuma K, Inoue T, Sasaki K, Sakata H, Ezura M, Uenohara H, Abe T, Tominaga T
Plasma tRNA derivatives concentrations for detecting early brain damage in patients with acute large vessel occlusion and predicting clinical outcomes after endovascular thrombectomy
Clin Neurol Neurosurg. 2022 SEP;220
Journal Impact Factor 2021: 1.885

#心臓 #循環器系
Yokota J, Takahashi R, Chiba T, Matsukawa Y, Matsushima K, Sasaki K
Dysphagia is an independent predictor of hospital-acquired disability in older patients with heart failure: a propensity score-matched analysis Predictors of HAD in older HF patients
Heart Vessels. 2023 JAN;38(1):66-76.
Journal Impact Factor 2021: 1.814


仙台西多賀病院

#医学 #一般医療 #内科学
Baba T, Takeda A, Murakami A, Koga T, Isomura T, Mori E, Grp DPS
Effect of donepezil for dementia prevention in Parkinson's disease with severe hyposmia (The DASH-PD study): A randomized long-term placebo-controlled trial
EClinicalMedicine. 2022 SEP;51
Journal Impact Factor 2021: 17.033

#医学 #一般医療 #内科学 #症例報告
Hashimoto K, Takahashi K, Onoki T, Kanno H, Morozumi N, Yamazaki S, Yahata K, Aizawa T
Destructive Spondyloarthropathy due to Congenital Insensitivity to Pain with Anhidrosis: A Case Report of Long-Term Follow-Up
Tohoku J Exp Med. 2022 OCT;258(2):91-95.
Journal Impact Factor 2021: 2.547

#行動科学
Shigemune Y, Kawasaki I, Baba T, Takeda A, Abe N
Decreased sensitivity to loss of options in patients with Parkinson's disease
Neuropsychologia. 2022 SEP 9;174
Journal Impact Factor 2021: 3.054

#臨床神経学
Takeda A, Tsuboi Y, Nomoto M, Mochizuki H, Hattori N
Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey
Parkinsons Dis. 2022 JUL 15;2022
Journal Impact Factor 2021: 3.17


あきた病院

#遺伝学 #遺伝 #症例報告
Obara K, Abe E, Mamiya S, Toyoshima I
Cerebellar Hypoperfusion in Two Patients with Cornelia de Lange Syndrome with Novel NIPBL Variants
Mol Syndromol. 2023 FEB;14(1):51-58.
Journal Impact Factor 2021: 1.494


水戸医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#医学 #一般医療 #内科学 #メタアナリシス
Tsutsumi Y, Tsujimoto Y, Tajika A, Omae K, Fujii T, Onishi A, Kataoka Y, Katsura M, Noma H, Sahker E, Ostinelli EG, Furukawa TA
Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews
BMJ Evid-Based Med. 2023 FEB;28(1):40-47.
Journal Impact Factor 2021: 5.696

#腫瘍学 #第II相試験
Moriwaki T, Nishina T, Sakai Y, Yamamoto Y, Shimada M, Ishida H, Amagai K, Sato M, Endo S, Negoro Y, Kuramochi H, Denda T, Hatachi Y, Ikezawa K, Nakajima G, Bando Y, Tsuji A, Yamamoto Y, Morimoto M, Kobayashi K, Hyodo I
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years
Jpn J Clin Oncol. 2022 JUL 8;52(7):717-726.
Journal Impact Factor 2021: 2.925


霞ヶ浦医療センター

#医学 #一般医療 #内科学 #症例報告
Hayashi T, Sekiguchi Y, Yamamoto S, Fujita H
'Vanishing' fragmented potential at the epicardium in a patient with Brugada syndrome
BMJ Case Rep. 2022 JUL;15(7)
Journal Impact Factor 2021: N/A


茨城東病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


高崎総合医療センター

#腫瘍学
Yasuoka H, Naganuma A, Kurihara E, Kobatake T, Ijima M, Tamura Y, Suzuki Y, Hoshino T, Ishida F, Hosaka H, Hatanaka T, Yoshida S, Aihara R, Hosouchi Y, Ishii N, Araki K, Shirabe K, Uraoka T, Kakizaki S
Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study
Oncology. 2022;100(8):449-459.
Journal Impact Factor 2021: 3.734

#医学 #一般医療 #内科学 #症例報告
Saito N, Hatanaka T, Nakano S, Hazama Y, Yoshida S, Hachisu Y, Tanaka Y, Yoshinaga T, Kashiwabara K, Norio K, Hosouchi Y, Tojima H, Kakizaki S, Uraoka T
A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab
Clin Case Rep. 2022 JUL;10(7)
Journal Impact Factor 2021: N/A

#腫瘍学 #レビュー論文
Nakazawa N, Sohda M, Ubukata Y, Kuriyama K, Kimura A, Kogure N, Hosaka H, Naganuma A, Sekiguchi M, Saito K, Ogata K, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H
Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study
Ann Surg Oncol. 2022 NOV;29(12):7400-7406.
Journal Impact Factor 2021: 4.339


東埼玉病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#臨床神経学
Wada A, Kawakami M, Yamada Y, Kaji K, Hijikata N, Liu FM, Otsuka T, Tsuji T
Relationship Between Pneumonia and Dysphagia in Patients With Multiple System Atrophy
Front Neurol. 2022 JUL 4;13
Journal Impact Factor 2021: 4.086


千葉医療センター

#複合科学
Iwamura C, Hirahara K, Kiuchi M, Ikehara S, Azuma K, Shimada T, Kuriyama S, Ohki S, Yamamoto E, Inaba Y, Shiko Y, Aoki A, Kokubo K, Hirasawa R, Hishiya T, Tsuji K, Nagaoka T, Ishkawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Tsukamoto T, Nakamura S, Urushibara T, Kaneda S, Sakao S, Tobiume M, Suzuki Y, Tsujiwaki M, Kubo T, Hasegawa T, Nakase H, Nishida O, Takahashi K, Baba K, Iizumi Y, Okazaki T, Kimura MY, Yoshino I, Igari H, Nakajima H, Suzuki T, Hanaoka H, Nakada T, Ikehara Y, Yokote K, Nakayama T
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity
Proc Natl Acad Sci U S A. 2022 AUG 16;119(33)
Journal Impact Factor 2021: 12.779


千葉東病院

#臨床神経学
Takeda T, Iijima M, Seki M, Higuchi E, Shimizu Y, Shibata N, Kitagawa K
Prolonged central motor conduction time and pyramidal tract degeneration in amyotrophic lateral sclerosis
Clin Neuropathol. 2022 JUL-AUG;41(4):157-161.
Journal Impact Factor 2021: 1.136


東京医療センター

#腫瘍学 #多施設共同研究
Tachibana H, Watanabe Y, Kurokawa S, Maeyama T, Hiroki T, Ikoma H, Hirashima H, Kojima H, Shiinoki T, Tanimoto Y, Shimizu H, Shishido H, Oka Y, Hirose TA, Kinjo M, Morozumi T, Kurooka M, Suzuki H, Saito T, Fujita K, Shirata R, Inada R, Yada R, Yamashita M, Kondo K, Hanada T, Takenaka T, Usui K, Okamoto H, Asakura H, Notake R, Kojima T, Kumazaki Y, Hatanaka S, Kikumura R, Nakajima M, Nakada R, Suzuki R, Mizuno H, Kawamura S, Nakamura M, Akimoto T
Multi-Institutional Study of End-to-End Dose Delivery Quality Assurance Testing for Image-Guided Brachytherapy Using a Gel Dosimeter
Brachytherapy. 2022 NOV-DEC;21(6):956-967.
Journal Impact Factor 2021: 2.441

#ヘルスケア科学 #サービス
Bito S, Hayashi Y, Fujita T, Yonemura S
Public Attitudes Regarding Trade-offs Between the Functional Aspects of a Contact-Confirming App for COVID-19 Infection Control and the Benefits to Individuals and Public Health: Cross-sectional Survey
JMIR Form Res. 2022 JUL;6(7)

#心臓 #循環器系 #多施設共同研究
Chishiki T, Nagatomo Y, Saji M, Takei M, Goda A, Kohno T, Nakano S, Nishihata Y, Ikegami Y, Shiraishi Y, Kohsaka S, Adachi T, Yoshikawa T, WET HF Investigators
Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice
Int J Cardiol. 2022 OCT 15;365:91-99.
Journal Impact Factor 2021: 4.039

#遺伝学 #遺伝 #症例報告
Hara-Isono K, Yamazawa K, Tanaka S, Nishi E, Fukami M, Kagami M
CDKN1C hyperexpression in two patients with severe growth failure and microdeletions affecting the paternally inherited KCNQ1OT1:TSS-DMR
J Med Genet. 2022 DEC;59(12):1241-1246.
Journal Impact Factor 2021: 5.945

#生化学 #分子生物学
Watanabe S, Ochiai H, Sakuma H, Mori T, Yazawa M, Oka A, Kishi K
Muscle Fiber Composition Changes after Selective Nerve Innervation
Int J Mol Sci. 2022 JUL;23(14)
Journal Impact Factor 2021: 6.208

#腫瘍学
Katoh Y, Yaguchi T, Kubo A, Iwata T, Morii K, Kato D, Ohta S, Satomi R, Yamamoto Y, Oyamada Y, Ouchi K, Takahashi S, Ishioka C, Matoba R, Suematsu M, Kawakami Y
Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody
J Immunother Cancer. 2022 JUL;10(7)
Journal Impact Factor 2021: 12.485

#眼科学
Iwata T
Japan to Global Eye Genetics Consortium: Extending Research Collaboration for Inherited Eye Diseases
Asia-Pac J Ophthalmol. 2022 JUL-AUG;11(4):360-368.
Journal Impact Factor 2021: 4.206

#内分泌学 #新陳代謝
Hara-Isono K, Nakamura A, Fuke TM, Inoue T, Kawashima S, Matsubara K, Sano S, Yamazawa K, Fukami M, Ogata T, Kagami M
Pathogenic Copy Number and Sequence Variants in Children Born SGA With Short Stature Without Imprinting Disorders
J Clin Endocrinol Metab. 2022 JUL 14;107(8):E3121-E3133.
Journal Impact Factor 2021: 6.134


災害医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#腫瘍学 #多施設共同研究 #観察研究
Ito T, Takashima A, Yamazaki K, Yukami H, Uetake H, Tsuda M, Suto T, Moriwaki T, Sugimoto N, Ojima H, Takii Y, Yasui H, Esaki T, Tsuji A, Goto M, Saruta M, Otsu S, Shinozaki K, Fujiwara T, Tamura T, Baba E, Shiozawa M, Denda T, Ueno H, Nagashima K, Shimada Y
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Int J Clin Oncol. 2022 SEP;27(9):1450-1458.
Journal Impact Factor 2021: 3.85

#消化器病学 #肝臓学
Sasaki Y, Abe T, Kawamura N, Keitoku T, Shibata I, Ohno S, Ono K, Makishima M
Prediction of the need for emergency endoscopic treatment for upper gastrointestinal bleeding and new score model: a retrospective study
BMC Gastroenterol. 2022 JUL 11;22(1)
Journal Impact Factor 2021: 2.848


東京病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#腫瘍学
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Ther Adv Med Oncol. 2022 JUL;14
Journal Impact Factor 2021: 5.485


村山医療センター

#整形外科学
Aoyama R, Yamane J, Ninomiya K, Takahashi Y, Kitamura K, Nori S, Suzuki S, Shiraishi T
Disc Height Narrowing Could Not Stabilize the Mobility at the Level of Cervical Spondylolisthesis: A Retrospective Study of 83 Patients with Cervical Single-Level Spondylolisthesis
Asian Spine J. 2023 FEB;17(1):138-148.
Journal Impact Factor 2021: N/A


横浜医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#医学 #一般医療 #内科学 #症例報告
Horiuchi H, Utada S, Shinomiya Y, Miyagawa T, Sogo A, Niida S, Okano H, Suzuki N, Otsuka T, Miyazaki H, Furuya R
Chronic Pulmonary Aspergillosis During Convalescence From Severe COVID-19 Treated With Oral Itraconazole: A Report of Two Cases
Cureus J Med Sci. 2022 JUL 26;14(7)
Journal Impact Factor 2021: N/A

#外科学
Watanabe K, Masuda H, Noma D
Anesthetic and analgesic techniques and perioperative inflammation may affect the timing of recurrence after complete resection for non-small-cell lung cancer
Front Surg. 2022 JUL 26;9
Journal Impact Factor 2021: 2.568

#医学 #一般医療 #内科学 #プロトコル論文
Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Yamamoto A, Takahashi K, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Yoneda M, Kobayashi N, Saito S, Nakajima A
Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study
BMJ Open. 2022 JUL;12(7)
Journal Impact Factor 2021: 3.007

#集中治療医学
Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K, Egi M, Hashimoto S, Shime N, Saito O, Matsumoto S, Nango E, Okada Y, Hayashi K, Sakuraya M, Nakajima M, Okamori S, Miura S, Fukuda T, Ishihara T, Kamo T, Yatabe T, Norisue Y, Aoki Y, Iizuka Y, Kondo Y, Narita C, Kawakami D, Okano H, Takeshita J, Anan K, Okazaki SR, Taito S, Hayashi T, Mayumi T, Terayama T, Kubota Y, Abe Y, Iwasaki Y, Kishihara Y, Kataoka J, Nishimura T, Yonekura H, Ando K, Yoshida T, Masuyama T, Sanui M, ARDS Clinical Practice Guideline 2, Japanese Soc Intensive Care Med, Japanese Resp Soc, Japanese Soc Resp Care Med
ARDS Clinical Practice Guideline 2021
J Intensive Care. 2022 JUL 8;10(1)
Journal Impact Factor 2021: 7.52


相模原病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#アレルギー
Takei M, Saito A, Yanagida N, Sato S, Ebisawa M
Cross-reactivity of each fraction among cereals in children with wheat allergy
Pediatr Allergy Immunol. 2022 JUL;33(7)
Journal Impact Factor 2021: 5.464

#臨床神経学 #レビュー論文
Iwabuchi K, Koyano S, Yagishita S
Simple and clear differentiation of spinocerebellar degenerations: Overview of macroscopic and low-power view findings
Neuropathology. 2022 OCT;42(5):379-393.
Journal Impact Factor 2021: 2.076


甲府病院

#整形外科学
Ochiai S, Hagino T, Senga S, Yamashita T, Ando T, Taniguchi N, Haro H
Analysis of Health-Related Quality of Life and Clinical Evaluations in Patients with the Triad of Combined Knee Injuries
J Knee Surg. 2023 SEP;36(11):1164-1170.
Journal Impact Factor 2021: 2.501


信州上田医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


金沢医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#呼吸器系 #多施設共同研究 #ランダム化比較試験
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K, Grp SGS
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
Eur Resp J. 2022 JUL 1;60(1)
Journal Impact Factor 2021: 33.801

#病理学
Kasashima S, Kawashima A, Kurose N, Ozaki S, Ikeda H, Harada K
The disturbance of the distribution of T helper cell subsets in the mantle area surrounding germinal centers in immunoglobulin G4-related sclerosing sialadenitis
Virchows Arch. 2022 NOV;481(5):767-777.
Journal Impact Factor 2021: 4.548


長良医療センター

#外科学 #ランダム化比較試験
Miyata R, Hamaji M, Nakakura A, Morita S, Shimazu Y, Ishikawa M, Kayawake H, Menju T, Sakaguchi Y, Sonobe M, Takahashi M, Aoyama A, Sumitomo R, Huang CL, Kono T, Miyahara R, Matsumoto A, Katakura H, Fukada T, Sakai H, Kobayashi M, Okumura N, Date N, Fujinaga T, Miyamoto E, Nakagawa T, Date H
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis
Surg Today. 2023 JAN;53(1):135-144.
Journal Impact Factor 2021: 2.54


天竜病院

#医学 #研究 #実験
Inoue M, Okamoto K
Japanese Parents? Experiences with Home-Based Interventions of Applied Behavior Analysis for Young Children with Autism Spectrum Disorders
Yonago Acta Med. 2022 AUG;65(3):266-269.
Journal Impact Factor 2021: 1.371


静岡医療センター

#心臓 #循環器系 #メタアナリシス #システマティックレビュー
Yokoyama Y, Kuno T, Morita SX, Slipczuk L, Takagi H, Briasoulis A, Latib A, Bangalore S, Heffron SP
Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
J Cardiol. 2022 NOV;80(5):416-422.
Journal Impact Factor 2021: 3.115

#心臓 #循環器系 #メタアナリシス
Yokoyama Y, Tsukagoshi J, Takagi H, Takayama H, Kuno T
Concomitant tricuspid annuloplasty in patients with mild to moderate tricuspid valve regurgitation undergoing mitral valve surgery: meta-analysis
J Cardiovasc Surg. 2022 OCT;63(5):624-631.
Journal Impact Factor 2021: 1.595

#心臓 #循環器系 #メタアナリシス #システマティックレビュー
Kuno T, Fujisaki T, Shoji S, Sahashi Y, Tsugawa Y, Iwagami M, Takagi H, Briasoulis A, Deharo P, Cuisset T, Latib A, Kohsaka S, Bhatt DL
Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis
Circ-Cardiovasc Interv. 2022 AUG;15(8)
Journal Impact Factor 2021: 7.514

#心臓 #循環器系 #レビュー論文
Ueyama H, Kuno T, Takagi H, Krishnamoorthy P, Prandi FR, Palazzuoli A, Sharma SK, Kini A, Lerakis S
Prognostic value of left ventricular global longitudinal strain in mitral regurgitation: a systematic review
Heart Fail Rev. 2023 MAR;28(2):465-483.
Journal Impact Factor 2021: 4.654


名古屋医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#血液学 #第II相試験 #第I相試験
Goto H, Ogawa C, Iida H, Horibe K, Oh I, Takada S, Maeda Y, Minami H, Nakashima Y, Morris JD, Kormany W, Chen YQ, Miyamoto T
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort
Acta Haematol. 2022;145(6):592-602.
Journal Impact Factor 2021: 3.068

#外科学
Inaishi T, Sakuma T, Fukuoka T, Ichihara S
Epithelioid myofibroblastoma of the breast: A case report and review of the literature
Int J Surg Case Rep. 2022 JUL;96
Journal Impact Factor 2021: N/A

#腫瘍学
Chalise L, Kato A, Ohno M, Maeda S, Yamamichi A, Kuramitsu S, Shiina S, Takahashi H, Ozone S, Yamaguchi J, Kato Y, Rockenbach Y, Natsume A, Todo T
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47? combination therapy against glioblastoma
Mol Ther-Oncolytics. 2022 SEP 15;26:265-274.
Journal Impact Factor 2021: 6.311

#微生物学
Mori M, Ode H, Kubota M, Nakata Y, Kasahara T, Shigemi U, Okazaki R, Matsuda M, Matsuoka K, Sugimoto A, Hachiya A, Imahashi M, Yokomaku Y, Iwatani Y
Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms
Microbiol Spectr. 2022 JUL-AUG;10(4)
Journal Impact Factor 2021: 9.043

#血液学
Yoshida M, Brown SA, Moriyama T, Nishii R, Tsujimoto S, Yamada Y, Yoshida K, Shirai R, Osumi T, Utano T, Fukano R, Kudo K, Sakaguchi K, Arakawa Y, Koh K, Sekiguchi M, Sekimizu M, Miyamura T, Ishida H, Inukai T, Tomizawa D, Kiyokawa N, Kato M, Yang JJ
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance
Br J Haematol. 2022 OCT;199(2):270-276.
Journal Impact Factor 2021: 8.615

#呼吸器系
Oki M, Handa H, Saka H, Kogure Y, Niwa H, Yamada A, Torii A, Ando M, Mineshita M
Changes in Pulmonary Function Test Results and Respiratory Symptoms before and after Airway Stent Removal
Respiration. 2022 OCT;101(10):925-930.
Journal Impact Factor 2021: 3.966

#血液学 #観察研究
Nakano Y, Adachi S, Nishiyama I, Yasuda K, Yoshida M, Iwano S, Kondo T, Murohara T
Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study
Thromb Res. 2022 AUG;216:113-119.
Journal Impact Factor 2021: 10.409

#腫瘍学 #第I相試験 #第II相試験
Ishizawa K, Yokoyama M, Kato H, Yamamoto K, Makita M, Ando K, Ueda Y, Tachikawa Y, Suehiro Y, Kurosawa M, Kameoka Y, Nagai H, Uoshima N, Ishikawa T, Hidaka M, Ito Y, Utsunomiya A, Fukushima K, Ogura M
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
Cancer Chemother Pharmacol. 2022 JUL;90(1):83-95.
Journal Impact Factor 2021: 3.288

#腫瘍学
INOUE S, SASSA N, KAWANISHI H, YUGUCHI Y, SUZUKI T, NAGAYAMA J, MATSUI H, MIYATA Y, SOEDA Y, TOCHIGI K, YAMAUCHI Y, MAEDA M, KOBAYASHI I, HATTORI R, MATSUKAWA Y, KATO M
Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial Cancer
Anticancer Res. 2022 JUL;42(7):3627-3636.
Journal Impact Factor 2021: 2.435

#腫瘍学
Matsumoto Y, Kawaguchi T, Watanabe M, Isa S, Ando M, Tamiya A, Kubo A, Kitagawa C, Yoshimoto N, Koh Y
Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
BMC Cancer. 2022 JUL 15;22(1)
Journal Impact Factor 2021: 4.638

#臨床神経学
Suzuki M, Nakamura T, Hirayama M, Ueda M, Hatanaka M, Harada Y, Nakatochi M, Nakatsubo D, Maesawa S, Saito R, Fujiwara K, Katsuno M
Wearable sensor device-based detection of decreased heart rate variability in Parkinson's disease
J Neural Transm. 2022 OCT;129(10):1299-1306.
Journal Impact Factor 2021: 3.85

#血液学
Edahiro Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito T, Kada A, Saito AM, Shimoda K, Sugimoto Y, Kurokawa T, Tomita A, Hashimoto Y, Akashi K, Matsumura I, Takenaka K, Komatsu N
Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study
Int J Hematol. 2022 NOV;116(5):696-711.
Journal Impact Factor 2021: 2.324

#外科学 #症例報告
Sakuma T, Yokoi A, Ichihara S
Appendiceal metastasis of gastric cancer clinically masquerading acute appendicitis: possible route of metastasis
J Surg Case Rep. 2022 JUL 1;2022(7)
Journal Impact Factor 2021: N/A

#臨床神経学
Kato S, Maesawa S, Bagarinao E, Nakatsubo D, Tsugawa T, Mizuno S, Kawabata K, Tsuboi T, Suzuki M, Shibata M, Takai S, Ishizaki T, Torii J, Mutoh M, Saito R, Wakabayashi T, Katsuno M, Ozaki N, Watanabe H, Sobue G
Magnetic resonance-guided focused ultrasound thalamotomy restored distinctive resting-state networks in patients with essential tremor
J Neurosurg. 2022 FEB;138(2):306-317.
Journal Impact Factor 2021: 5.526


豊橋医療センター

#外科学
Inaishi T, Sakuma T, Fukuoka T, Ichihara S
Epithelioid myofibroblastoma of the breast: A case report and review of the literature
Int J Surg Case Rep. 2022 JUL;96
Journal Impact Factor 2021: N/A

#整形外科学
Inoue J, Takenaga T, Tsuchiya A, Okubo N, Takeuchi S, Takaba K, Nozaki M, Kobayashi M, Fukushima H, Kato J, Murakami H, Yoshida M
Ultrasound Assessment of Anterior Humeral Head Translation in Patients With Anterior Shoulder Instability: Correlation With Demographic, Radiographic, and Clinical Data
Orthop J Sports Med. 2022 JUL;10(7)
Journal Impact Factor 2021: 3.401

#外科学 #症例報告
Sakuma T, Yokoi A, Ichihara S
Appendiceal metastasis of gastric cancer clinically masquerading acute appendicitis: possible route of metastasis
J Surg Case Rep. 2022 JUL 1;2022(7)
Journal Impact Factor 2021: N/A


鈴鹿病院

#臨床神経学 #症例報告
Mizutani K, Sakurai K, Uchida Y, Oguri T, Kato H, Yoshida M, Sone J, Yuasa H, Matsukawa N
Absence of diffusion-weighted imaging abnormalities in a patient with neuronal intranuclear inclusion disease
Neurol Sci. 2022 NOV;43(11):6551-6554.
Journal Impact Factor 2021: 3.83


三重中央医療センター

#発生生物学
Takada K, Shimodai-Yamada S, Suzuki M, Trinh QD, Takano C, Kawakami K, Asai-Sato M, Komatsu A, Okahashi A, Nagano N, Misawa T, Yamaguchi K, Suzuki T, Kawana K, Morioka I, Yamada H, Hayakawa S, Hao H, Komine-Aizawa S
Restriction of SARS-CoV-2 replication in the human placenta
Placenta. 2022 SEP;127:73-76.
Journal Impact Factor 2021: 3.287

#複合科学 #多施設共同研究
Tanioka S, Yago T, Tanaka K, Ishida F, Kishimoto T, Tsuda K, Ikezawa M, Araki T, Miura Y, Suzuki H
Machine learning prediction of hematoma expansion in acute intracerebral hemorrhage
Sci Rep. 2022 JUL 21;12(1)
Journal Impact Factor 2021: 4.997


あわら病院

#心臓 #循環器系
Morishita T, Uzui H, Mitsuke Y, Tada H
Prognostic value of 1,5-anhydro-d-glucitol incorporating syntax score in acute coronary syndrome
Heart Vessels. 2023 JAN;38(1):8-17.
Journal Impact Factor 2021: 1.814


東近江総合医療センター

#神経科学
Yoshihara Y, Kato T, Watanabe D, Fukumoto M, Wada K, Oishi N, Nakakura T, Kuriyama K, Shirasaka T, Murai T
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD4
J Neurovirol. 2022 JUN;28(3):355-366.
Journal Impact Factor 2021: 3.739


京都医療センター

#心臓 #循環器系 #観察研究 #多施設共同研究
Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K, Shimizu W, Suzuki S, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Morishima Y, Takita A, Inoue H
Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation
Circ J. 2023 JAN;87(1):6-+.
Journal Impact Factor 2021: 3.35

#心臓 #循環器系 #多施設共同研究
Hiramori S, Yamashita Y, Morimoto T, Kadota K, Takase T, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Inoko M, Tada T, Izumi T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Matsuda M, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Nakagawa Y, Kato T, Ono K, Ando K, Kimura T, COMMAND VTE Registry Investigators
Optimal quality of vitamin K antagonist therapy in Japanese patients with venous thromboembolism
J Cardiol. 2022 NOV;80(5):487-494.
Journal Impact Factor 2021: 3.115

#呼吸器系 #症例報告
Fujita K, Okamura M, Imakita T, Yamamoto Y, Sawai S, Moriyoshi K, Mio T
Natural course of pulmonary hyalinizing granuloma over a decade
Respir Med Case Rep. 2022;39
Journal Impact Factor 2021: N/A

#内分泌学 #新陳代謝 #多施設共同研究
Spyroglou A, Handgriff L, Müller L, Schwarzlmüller P, Parasiliti-Caprino M, Fuss CT, Remde H, Hirsch A, O'Toole SM, Thuzar M, Petramala L, Letizia C, Deflorenne E, Amar L, Vrckovnik R, Kocjan T, Zhang CD, Li DF, Singh S, Katabami T, Yoneda T, Murakami M, Wada N, Inagaki N, Quinkler M, Ghigo E, Maccario M, Stowasser M, Drake WM, Fassnacht M, Bancos I, Reincke M, Naruse M, Beuschlein F
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects
Eur J Endocrinol. 2022 SEP;187(3):361-372.
Journal Impact Factor 2021: 6.558

#内分泌学 #新陳代謝
Kometani M, Yoneda T, Karashima S, Takeda Y, Tsuiki M, Yasoda A, Kurihara I, Wada N, Katabami T, Sone M, Ichijo T, Tamura K, Ogawa Y, Kobayashi H, Okamura S, Inagaki N, Kawashima J, Fujita M, Oki K, Matsuda Y, Tanabe A, Naruse M
Effect of Intraprocedural Cortisol Measurement on ACTH-stimulated Adrenal Vein Sampling in Primary Aldosteronism
J Endocr Soc. 2022 SEP 1;6(9)
Journal Impact Factor 2021: N/A

#心臓 #循環器系
Masunaga N, Ogawa H, Minami K, Ishigami K, Ikeda S, Doi K, Hamatani Y, Yoshizawa T, Ide Y, Fujino A, Ishii M, Iguchi M, Wada H, Hasegawa K, Tsuji H, Esato M, Abe M, Akao M, Fushimi AF Registry Investigators
Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation-The Fushimi AF Registry
Circ J. 2022 AUG;86(8):1252-+.
Journal Impact Factor 2021: 3.35

#救急医学
Coccolini F, Sartelli M, Kluger Y, Osipov A, Cui YF, Beka SG, Kirkpatrick A, Sall I, Moore EE, Biffl WL, Litvin A, Pisano M, Magnone S, Picetti E, de Angelis N, Stahel P, Ansaloni L, Tan E, Abu-Zidan F, Ceresoli M, Hecker A, Chiara O, Sganga G, Khokha V, di Saverio S, Sakakushev B, Campanelli G, Fraga G, Wani I, ten Broek R, Cicuttin E, Cremonini C, Tartaglia D, Soreide K, Galante J, de Moya M, Koike K, De Simone B, Balogh Z, Amico F, Shelat V, Pikoulis E, Di Carlo I, Bonavina L, Leppaniemi A, Marzi I, Ivatury R, Khan J, Maier RV, Hardcastle TC, Isik A, Podda M, Tolonen M, Rasa K, Navsaria PH, Demetrashvili Z, Tarasconi A, Carcoforo P, Sibilla MG, Baiocchi GL, Pararas N, Weber D, Chiarugi M, Catena F
The LIFE TRIAD of emergency general surgery
World J Emerg Surg. 2022 JUL 25;17(1)
Journal Impact Factor 2021: 8.165

#複合科学
Yamasaki T, Horie T, Koyama S, Nakao T, Baba O, Kimura M, Sowa N, Sakamoto K, Yamazaki K, Obika S, Kasahara Y, Kotera J, Oka K, Fujita R, Sasaki T, Takemiya A, Hasegawa K, Minatoya K, Kimura T, Ono K
Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways
Sci Rep. 2022 JUL 14;12(1)
Journal Impact Factor 2021: 4.997

#泌尿器学 #腎臓学 #症例報告
Tanaka Y, Hirai D, Kawai Y, Ueda N, Takaori K, Koizumi M, Seta K
Peritoneal dialysis-related peritonitis caused by Rhodococcus corynebacterioides
CEN CASE REP. 2023 FEB;12(1):68-72.
Journal Impact Factor 2021: N/A

#整形外科学
Honda S, Fujibayashi S, Shimizu T, Tsubouchi N, Kanba Y, Sono T, Kimura H, Odate S, Onishi E, Tamaki Y, Tomizawa T, Tsutsumi R, Yasura K, Murata K, Otsuki B, Matsuda S
Neurological severity evaluation using magnetic resonance imaging in acute spontaneous spinal epidural haematomas
Int Orthop. 2022 OCT;46(10):2347-2355.
Journal Impact Factor 2021: 3.479

#泌尿器学 #腎臓学
Kato T, Yokomizo A, Matsumoto R, Tohi Y, Miyakawa J, Mitsuzuka K, Sasaki H, Inokuchi J, Matsumura M, Sakamoto S, Kinoshita H, Fukuhara H, Kamiya N, Kimura R, Nitta M, Okuno H, Akakura K, Kakehi Y, Sugimoto M
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study
Int J Urol. 2022 NOV;29(11):1271-1278.
Journal Impact Factor 2021: 2.896

#血液学
Morita Y, Nannya Y, Ichikawa M, Hanamoto H, Shibayama H, Maeda Y, Hata T, Miyamoto T, Kawabata H, Takeuchi K, Tanaka H, Kishimoto J, Miyano S, Matsumura I, Ogawa S, Akashi K, Kanakura Y, Mitani K
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial
Int J Hematol. 2022 NOV;116(5):659-668.
Journal Impact Factor 2021: 2.324

#血液学 #第III相試験 #多施設共同研究 #ランダム化比較試験
Kawabata H, Tamura T, Tamai S, Fujibayashi A, Sugimura M, Study Grp
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Int J Hematol. 2022 NOV;116(5):647-658.
Journal Impact Factor 2021: 2.324


宇多野病院

#臨床神経学 #症例報告
Ohara H, Shimizu H, Kasamatsu T, Kajita A, Uno K, Lai KW, Vellingiri B, Sugie K, Kinoshita M
Cytotoxic lesions of the corpus callosum after COVID-19 vaccination
Neuroradiology. 2022 OCT;64(10):2085-2089.
Journal Impact Factor 2021: 2.995


大阪医療センター

#心臓 #循環器系 #観察研究 #多施設共同研究
Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K, Shimizu W, Suzuki S, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Morishima Y, Takita A, Inoue H
Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation
Circ J. 2023 JAN;87(1):6-+.
Journal Impact Factor 2021: 3.35

#外科学
Yoshitatsu S, Shiraishi M, Arika T
A fascia bow traction method for the treatment of unilateral marginal mandibular nerve paralysis after mandibulectomy for head and neck cancer
JPRAS Open. 2022 DEC;34:51-59.

#皮膚病学
Goto K, Ogawa K, Hishima T, Oishi N, Tomita O, Tsuyuki T, Oda T, Iwahashi Y, Inaba Y, Honma K
Seborrheic Keratosis With Malignant Transformation (Invasive or Noninvasive Squamous Cell Carcinoma Arising in Seborrheic Keratosis): A Clinicopathologic and Immunohistochemical Study of 11 Cases
Am J Dermatopathol. 2022 DEC;44(12):891-899.
Journal Impact Factor 2021: 1.319

#皮膚病学 #症例報告
Bun S, Goto K, Oishi T, Kiyohara Y, Tsutsumida A, Yoshikawa S
Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum
Am J Dermatopathol. 2022 NOV;44(11):850-854.
Journal Impact Factor 2021: 1.319

#臨床神経学
Fujiwara S, Sakai N, Imamura H, Ohara N, Tanaka K, Yamagami H, Matsumoto Y, Takeuchi M, Uchida K, Yoshimura S, Morimoto T, RESCUE-Japan Registry 2 Investigat
Association between anemic status on admission and clinical outcomes of acute large vessel occlusion
J Neurol Sci. 2022 SEP 15;440
Journal Impact Factor 2021: 4.553

#心臓 #循環器系 #症例報告
Horiuchi K, Kosugi S, Abe H, Ueda Y
Fulminant myocarditis after the first dose of mRNA-1273 vaccination in a patient with previous COVID-19: a case report
Eur Heart J-Case Rep. 2022 JUL 6;6(7)
Journal Impact Factor 2021: N/A

#医学 #一般医療 #内科学
Katayama Y, Tanaka K, Ishida K, Hirose T, Tachino J, Nakao S, Umemura Y, Kiyohara K, Ojima M, Kiguchi T, Kitamura T, Oda J
Factors Associated with Traumatic Diaphragmatic Rupture among Patients with Chest or Abdominal Injury: A Nationwide Study from Japan
J Clin Med. 2022 AUG;11(15)
Journal Impact Factor 2021: 4.964

#腫瘍学 #第I相試験 #多施設共同研究
Kotani H, Masuda N, Yamashita T, Naito Y, Taira T, Inoue K, Takahashi M, Yonemori K, Toyoizumi S, Mori Y, Nagasawa T, Hori N, Iwata H
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
Breast Cancer. 2022 NOV;29(6):1088-1098.
Journal Impact Factor 2021: 3.307

#工学 #生医学
Tanaka A, Kiriyama Y, Kubo N, Sakaguchi R, Uchiyama A, Fujino Y
Noninvasive blood pressure measurement in patients with continuous-flow left ventricular assist devices
J Artif Organs. 2023 JUN;26(2):160-164.
Journal Impact Factor 2021: 1.385

#泌尿器学 #腎臓学 #症例報告
Kimura Y, Mori Y, Notsu S, Bessho S, Kobori A, Kubota T, Shimomura A, Iwatani H
Severe leukocytopenia due to copper deficiency induced by zinc supplementation in a patient on peritoneal dialysis: a case report
CEN CASE REP. 2023 FEB;12(1):78-83.
Journal Impact Factor 2021: N/A

#腫瘍学
Matsumae T, Kodama T, Myojin Y, Maesaka K, Sakamori R, Takuwa A, Oku K, Motooka D, Sawai Y, Oshita M, Nakabori T, Ohkawa K, Miyazaki M, Tanaka S, Mita E, Tawara S, Yakushijin T, Nozaki Y, Hagiwara H, Tahata Y, Yamada R, Hikita H, Tatsumi T, Takehara T
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
Cancers. 2022 JUL;14(14)
Journal Impact Factor 2021: 6.575

#腫瘍学 #プロトコル論文
Endo S, Terazawa T, Goto M, Tanaka R, Kato T, Fujitani K, Kawakami H, Sakai D, Kurokawa Y, Tsujinaka T, Shimokawa T, Satoh T
Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study
BMC Cancer. 2022 JUL 23;22(1)
Journal Impact Factor 2021: 4.638

#臨床神経学
Nguyen TN, Qureshi MM, Klein P, Yamagami H, Mikulik R, Etminan N, Abdalkader M, Mansour OY, Czlonkowska A, Lo H, Sathya A, Demeestere J, Tsivgoulis G, Sakai N, Sedova P, Kristoffersen ES, Mohammaden M, Lereis VP, Scollo SD, Ma A, Rahman A, Bonnet T, Cortier J, De Raedt S, Lemmens R, Ligot N, Hidalgo RCT, Cuervo DLM, Neves LD, Rezende MTS, Santiago IB, Sirakov A, Sirakov S, Cora EA, Kelly ME, Lavoie P, Peeling L, Pikula A, Rivera R, Chen HS, Chen YM, Fang HL, Bedekovic MR, Budincevic H, Strossmayer JJ, Hrabanovska E, Jurák L, Cabal M, Kadlckova J, Karpowicz I, Palousková H, Reiser M, Klecka L, Kovár M, Neumann J, Reková P, Srámek M, Vítková E, Skorna M, Záková L, Sobh K, Alpay K, Rautio R, Strbian D, Gentric JC, Magro E, Naggara O, Reiner P, Abdulazim A, Bohmann FO, Boskamp S, Gerber JC, Kaiser DPO, Kestner RI, Mbroh J, Neyazi M, Rosenkranz M, Sani AF, Poli S, Thomalla G, Karapanayiotides T, Kargiotis O, Koutroulou I, Palaiodimou L, Guerra JDB, Huded V, Nagendra S, Prajapati C, Krishna A, Ghoreishi A, Ilkhchi RB, Jalili J, Sabetay SI, Abu Raya T, Acampa M, Longoni M, Bigliani CR, Castellan L, Ornello R, Renieri L, Romoli M, Sacco S, Sangalli D, Viganò M, Zini A, Tokimura H, Sonoda K, Todo K, Fukuda H, Fujita K, Sakaguchi M, Uno M, Kan I, Kosuke M, Kono R, Kimura N, Yamamoto N, Yamamoto R, Doijiri R, Shindo S, Ohara N, Imamura H, Ogawa T, Uwatoko T, Kanamaru T, Fujinaka T, Takenobu Y, Toyoda K, Matsumaru Y, Yazawa Y, Sugiura Y, Baek JH, Sunmonu TA, Kwon YS, Lee YH, Seo KD, Sohn SI, Chan YC, Zaidi WAW, Barrientos-Prieto J, Gongora-Rivera F, Martinez-Marino M, Calderón-Vallejo A, Groppa S, Pavel L, Coutinho JM, Dippel D, Rinkel L, Van Dam-Nolen DHK, Nwazor EO, Al Hashimi AM, Ahmad S, Rashid U, Rodriguez-Kadota L, Vences MA, Yalung PM, Dy JSH, Brola W, Dorobek M, Karlinski MA, Labuz-Roszak BM, Lasek-Bal A, Sienkiewicz-Jarosz H, Staszewski J, Sobolewski P, Zielinska-Turek J, Araújo AP, Fonseca L, Debiec A, Silva ML, Castro P, Rocha M, Falup-Pecurariu RC, Venketasubramanian N, Mako GKM, Ayo-Martin O, Wiacek M, Blasco J, Cruz-Culebras A, Hernandez-Fernandez F, Fernandez CR, Lopez JE, Rodriguez A, Bolognese M, Karwacki GM, Keller E, Machi P, Bernava G, Boonyakarnkul S, Churojana A, Hammami N, Bajrami A, Senadim S, Hussain S, John S, Dow G, Krishnan K, Lenthall R, Wong K, Zhang LQ, Altschul D, Asif KS, Aziz-Sultan MA, Bach I, Below K, Biller J, Cervantes-Arslanian AM, Chaudhry SA, Chebl A, Chen M, Colasurdo M, Czap A, Dasenbrock H, Bahiru Z, de Havenon AH, Dharmadhikari S, Dmytriw AA, Eskey CJ, Etherton M, Ezepue C, Fink L, Gasimova U, Goyal N, Grimmett KB, Hakemi M, Hester T, Inoa V, Kan PT, Kasper EM, Khandelwal P, Khatri R, Khoury NN, Kim BS, Kolikonda M, Kuhn AL, Linares G, Linfante I, Loochtan A, Lukovits TG, Male SS, Khawaja AM, Maali L, Galecio-Castillo EM, Min JY, Mohamed GA, Nalleballe K, Ortega-Gutierrez S, Radaideh Y, Ramakrishnan P, Masoud HE, Reddy AB, Ruland S, Omran SS, Sheth SA, Puri AS, Rahangdale RH, Siegler JE, Starosciak AK, Tarlov NE, Taylor RA, Tsai J, Wang MJ, Wong KH, Zaidat OO, Le HV, Phan HT, Ton MD, Tran AD, Sirakova K, Pham TN, Möhlenbruch MA, Nagel S, Raymond J, Nogueira RG, SVIN COVID-19 Global SAH Registry
Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up
J Neurol Neurosurg Psychiatry. 2022 OCT;93(10):1028-1038.
Journal Impact Factor 2021: 13.654

#ヘルスケア科学 #サービス
Matsuda Y, Hasuo H, Narita K, Matsuoka H, Morita R, Kiuchi D, Ikari T, Hori T, Okazaki K, Sakai K, Aiki S, Okabayashi H, Oyamada S, Ariyoshi K, Tokoro A, Fukunaga M
Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study
BMJ Support Palliat Care. 2023 DEC;13(E3):e1126-e1132.
Journal Impact Factor 2021: 4.633

#腫瘍学
Udagawa H, Takahashi S, Hirao M, Tahara M, Iwasa S, Sato Y, Hamakawa T, Shitara K, Horinouchi H, Chin K, Masuda N, Suzuki T, Okumura S, Takase T, Nagai R, Yonemori K
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer
Cancer Med. 2023 JAN;12(2):1269-1278.
Journal Impact Factor 2021: 4.711

#腫瘍学 #多施設共同研究
Tsukushi S, Nishida Y, Hirose T, Nakata E, Nakagawa R, Nakamura T, Imanishi J, Nagano A, Tamiya H, Ueda T, Japanese Musculoskeletal Oncology
Short-term clinical outcomes of Kyocera Modular Limb Salvage System designed cementless stems for the endoprosthetic reconstruction of lower extremities: a Japanese Musculoskeletal Oncology Group multi-institutional study
BMC Cancer. 2022 JUL 16;22(1)
Journal Impact Factor 2021: 4.638

#腫瘍学 #多施設共同研究
Kato T, Fujita K, Minami T, Nagahara A, Hyashi Y, Nakata W, Matsuzaki K, Nakano K, Hatano K, Kawashima A, Imamura R, Takada S, Nishimura K, Tsujihata M, Takao T, Nakai Y, Nakayama M, Nishimura K, Uemura M, Uemura H, Nonomura N
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study
Int J Clin Oncol. 2022 OCT;27(10):1596-1604.
Journal Impact Factor 2021: 3.85

#血液学
Morita Y, Nannya Y, Ichikawa M, Hanamoto H, Shibayama H, Maeda Y, Hata T, Miyamoto T, Kawabata H, Takeuchi K, Tanaka H, Kishimoto J, Miyano S, Matsumura I, Ogawa S, Akashi K, Kanakura Y, Mitani K
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial
Int J Hematol. 2022 NOV;116(5):659-668.
Journal Impact Factor 2021: 2.324

#耳鼻咽喉科学
Akama T, Tsuda T, Terada R, Tanaka S, Tanaka H, Yoshitatsu S, Nishimura H, Inohara H
A Case of Traumatic Nasal Valve Stenosis Successfully Treated with Open Rhinoplasty and Z-Plasty
ENT-Ear Nose Throat J. 2022 JUL 12;
Journal Impact Factor 2021: 1.677

#神経科学
Yoshihara Y, Kato T, Watanabe D, Fukumoto M, Wada K, Oishi N, Nakakura T, Kuriyama K, Shirasaka T, Murai T
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD4
J Neurovirol. 2022 JUN;28(3):355-366.
Journal Impact Factor 2021: 3.739


近畿中央呼吸器センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#医学 #一般医療 #内科学 #症例報告
Moda M, Arai T, Takeuchi N, Kagawa T, Takimoto T, Sumikawa H, Shimizu S, Inoue Y
Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration
Intern Med. 2023;62(4):577-582.
Journal Impact Factor 2021: 1.282

#感染症
Yoshida S, Tsuyuguchi K, Kobayashi T, Shimatani Y, Inoue Y
Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type
Diagn Microbiol Infect Dis. 2022 NOV;104(3)
Journal Impact Factor 2021: 2.983

#ヘルスケア科学 #サービス
Matsuda Y, Hasuo H, Narita K, Matsuoka H, Morita R, Kiuchi D, Ikari T, Hori T, Okazaki K, Sakai K, Aiki S, Okabayashi H, Oyamada S, Ariyoshi K, Tokoro A, Fukunaga M
Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study
BMJ Support Palliat Care. 2023 DEC;13(E3):e1126-e1132.
Journal Impact Factor 2021: 4.633

#腫瘍学
Matsumoto Y, Kawaguchi T, Watanabe M, Isa S, Ando M, Tamiya A, Kubo A, Kitagawa C, Yoshimoto N, Koh Y
Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
BMC Cancer. 2022 JUL 15;22(1)
Journal Impact Factor 2021: 4.638

#神経科学
Matsugi A, Nishishita S, Yoshida N, Tanaka H, Douchi S, Bando K, Tsujimoto K, Honda T, Kikuchi Y, Shimizu Y, Odagaki M, Nakano H, Okada Y, Mori N, Hosomi K, Saitoh Y
Impact of Repetitive Transcranial Magnetic Stimulation to the Cerebellum on Performance of a Ballistic Targeting Movement
Cerebellum. 2023 AUG;22(4):680-697.
Journal Impact Factor 2021: 3.648

#麻酔学 #多施設共同研究 #観察研究
Ishiki H, Hasuo H, Matsuda Y, Matsuoka H, Hiramoto S, Higuchi M, Yoshida K, Tokoro A, Hatano Y, Hori T, Kinkawa J, Nojima M
Prevalence of Myofascial Pain Syndrome and Efficacy of Trigger Point Injection in Patients with Incurable Cancer: A Multicenter, Prospective Observational Study (MyCar Study)
Pain Med. 2022 JUL 1;23(7):1259-1265.
Journal Impact Factor 2021: 3.637


大阪刀根山医療センター

#複合科学
Yasumizu Y, Ohkura N, Murata H, Kinoshita M, Funaki S, Nojima S, Kido K, Kohara M, Motooka D, Okuzaki D, Suganami S, Takeuchi E, Nakamura Y, Takeshima Y, Arai M, Tada S, Okumura M, Morii E, Shintani Y, Sakaguchi S, Okuno T, Mochizuki H
Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma
Nat Commun. 2022 JUL 22;13(1)
Journal Impact Factor 2021: 17.694

#腫瘍学 #多施設共同研究
Sugimoto T, Fujimoto D, Sato Y, Tamiya M, Yokoi T, Taniguchi Y, Hino A, Hata A, Uchida J, Fukuda Y, Hara S, Kanazu M, Matsumoto H, Kokubo M, Yamamoto N
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
Lung Cancer. 2022 SEP;171:3-8.
Journal Impact Factor 2021: 6.081

#免疫学
Kuge T, Fukushima K, Matsumoto Y, Saito H, Abe Y, Akiba E, Haduki K, Nitta T, Kawano A, Tanaka M, Hattori Y, Kawasaki T, Matsuki T, Shiroyama T, Motooka D, Tsujino K, Miki K, Mori M, Kitada S, Nakamura S, Iida T, Kumanogoh A, Kida H
Chronic Pulmonary Disease Caused by Tsukamurella toyonakaense
Emerg Infect Dis. 2022 JUL;28(7):1437-1441.
Journal Impact Factor 2021: 16.126

#腫瘍学 #第II相試験
Fukuda M, Yamaguchi M, Yamazaki T, Funaki S, Mukae H, Fukuoka J, Nabeshima K, Tateyama H, Ashizawa K, Tomiyama N, Hara M, Seto T, Okumura M, Sugio K
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study
Thorac Cancer. 2022 SEP;13(17):2499-2506.
Journal Impact Factor 2021: 3.223

#腫瘍学
Akazawa Y, Yoshikawa A, Kanazu M, Yano Y, Yamaguchi T, Mori M
Non-small cell lung cancer with tumor proportion score > 90% could increase the risk of severe immune-related adverse events in first-line treatments with immune checkpoint inhibitors: A retrospective single-center study
Thorac Cancer. 2022 SEP;13(17):2450-2458.
Journal Impact Factor 2021: 3.223

#腫瘍学 #第I相試験
Otsuka T, Nishida S, Shibahara T, Temizoz B, Hamaguchi M, Shiroyama T, Kimura K, Miyake K, Hirata H, Mizuno Y, Yagita M, Manabe Y, Kuroda E, Takeda Y, Kida H, Ishii KJ, Kumanogoh A
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
BMC Cancer. 2022 JUL 7;22(1)
Journal Impact Factor 2021: 4.638

#腫瘍学
Kawachi H, Tamiya M, Taniguchi Y, Yokoyama T, Yokoe S, Oya Y, Imaji M, Okabe F, Kanazu M, Sakata Y, Uematsu S, Tanaka S, Arai D, Saito G, Kobe H, Miyauchi E, Okada A, Hara S, Kumagai T
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study
JTO Clin Res Rep. 2022 JUL;3(7)


大阪南医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#心臓 #循環器系
Kondo T, Higo S, Shiba M, Kohama Y, Kameda S, Tabata T, Inoue H, Okuno S, Ogawa S, Nakamura S, Takeda M, Ito E, Li J, Liu L, Kuramoto Y, Lee JK, Takashima S, Miyagawa S, Sawa Y, Hikoso S, Sakata Y
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy
Circ-Genom Precis Med. 2022 OCT;15(5):429-443.
Journal Impact Factor 2021: 7.465

#工学 #生医学 #レビュー論文
Sugano N, Hamada H, Uemura K, Takashima K, Nakahara I
Numerical analysis evaluation of artificial joints
J Artif Organs. 2022 SEP;25(3):185-190.
Journal Impact Factor 2021: 1.385

#消化器病学 #肝臓学
Tahata Y, Sakamori R, Yamada R, Kodama T, Hikita H, Nozaki Y, Oshita M, Hiramatsu N, Miyazaki M, Mita E, Yamamoto K, Ohkawa K, Kaneko A, Ito T, Doi Y, Yakushijin T, Hijioka T, Fukui H, Imanaka K, Yoshida Y, Yamada Y, Tatsumi T, Takehara T
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis
Hepatol Res. 2022 OCT;52(10):824-832.
Journal Impact Factor 2021: 4.942


奈良医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


南和歌山医療センター

#消化器病学 #肝臓学
Tahata Y, Sakamori R, Yamada R, Kodama T, Hikita H, Nozaki Y, Oshita M, Hiramatsu N, Miyazaki M, Mita E, Yamamoto K, Ohkawa K, Kaneko A, Ito T, Doi Y, Yakushijin T, Hijioka T, Fukui H, Imanaka K, Yoshida Y, Yamada Y, Tatsumi T, Takehara T
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis
Hepatol Res. 2022 OCT;52(10):824-832.
Journal Impact Factor 2021: 4.942


和歌山病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


松江医療センター

#眼科学 #症例報告
Shimizu H, Shimizu M, Nakano T, Noda K, Tanito M
Multimodal Imaging Findings in Retinopathy Associated with Facioscapulohumeral Muscular Dystrophy before and after Treatment with Intravitreal Aflibercept and Laser Photocoagulation
Case Rep in Ophthalmology. 2022;13(2):556-561.
Journal Impact Factor 2021: N/A

#臨床神経学
Nonaka M, Komori Y, Isozaki H, Ueno K, Kamei T, Takeda J, Nonaka Y, Yabe I, Zaitsu M, Nakashima K, Asai A
Current status and challenges of neurosurgical procedures for patients with myelomeningocele in real-world Japan
Childs Nerv Syst. 2023 NOV;39(11):3137-3145.
Journal Impact Factor 2021: 1.532


岡山医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#泌尿器学 #腎臓学
Matsumoto J, Iwata N, Watari S, Ushio S, Shiromizu S, Takeda T, Hamano H, Kajizono M, Araki M, Nasu Y, Ariyoshi N, Zamami Y
Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System
Eur Urol Focus. 2023 JAN;9(1):141-144.
Journal Impact Factor 2021: 5.952

#呼吸器系 #多施設共同研究 #ランダム化比較試験
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K, Grp SGS
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
Eur Resp J. 2022 JUL 1;60(1)
Journal Impact Factor 2021: 33.801

#腫瘍学
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Ther Adv Med Oncol. 2022 JUL;14
Journal Impact Factor 2021: 5.485

#小児科学
Aoki H, Shibasaki J, Tsuda K, Yamamoto K, Takeuchi A, Sugiyama Y, Isayama T, Mukai T, Ioroi T, Yutaka N, Takahashi A, Tokuhisa T, Nabetani M, Iwata O, Japan Collaboration Team
Predictive value of the Thompson score for short-term adverse outcomes in neonatal encephalopathy
Pediatr Res. 2023 MAR;93(4):1057-1063.
Journal Impact Factor 2021: 3.953

#遺伝学 #遺伝
Sofronova V, Fukushima Y, Masuno M, Naka M, Nagata M, Ishihara Y, Miyashita Y, Asano Y, Moriwaki T, Iwata R, Terawaki S, Yamanouchi Y, Otomo T
A novel nonsense variant in ARID1B causing simultaneous RNA decay and exon skipping is associated with Coffin-Siris syndrome
Hum Genom Var. 2022 JUL 25;9(1)
Journal Impact Factor 2021: N/A

#腫瘍学 #第I相試験 #第II相試験
Ishizawa K, Yokoyama M, Kato H, Yamamoto K, Makita M, Ando K, Ueda Y, Tachikawa Y, Suehiro Y, Kurosawa M, Kameoka Y, Nagai H, Uoshima N, Ishikawa T, Hidaka M, Ito Y, Utsunomiya A, Fukushima K, Ogura M
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
Cancer Chemother Pharmacol. 2022 JUL;90(1):83-95.
Journal Impact Factor 2021: 3.288


南岡山医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


呉医療センター

#医学 #一般医療 #内科学 #症例報告
Hayashino K, Zaitsu J, Kuraoka K, Hirata T
Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin
Intern Med. 2023;62(4):655-659.
Journal Impact Factor 2021: 1.282

#感染症 #症例報告
Kitahara Y, Nakamura R, Okimoto M, Miwata K, Ito N, Takafuta T
Concurrent coronavirus disease 2019 and primary syphilis in a young man: A rare case report
J Infect Chemother. 2022 NOV;28(11):1552-1557.
Journal Impact Factor 2021: 2.065

#腫瘍学
Yukihiro K, Teishima J, Goto K, Aoki G, Sekino Y, Hayashi T, Hasegawa Y, Mita K, Kato M, Kajiwara M, Shigeta M, Maruyama S, Kadonishi Y, Fujiwara S, Hinata N
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor
Urol Oncol-Semin Orig Investig. 2022 OCT;40(10)
Journal Impact Factor 2021: 2.954

#外科学 #多施設共同研究
Suto H, Kamei K, Kato H, Misawa T, Unno M, Nitta H, Satoi S, Kawabata Y, Ohtsuka M, Rikiyama T, Sudo T, Matsumoto I, Hirao T, Okano K, Suzuki Y, Sata N, Isaji S, Sugiyama M, Takeyama Y
Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in Japan
Surgery. 2022 SEP;172(3):962-967.
Journal Impact Factor 2021: 4.348

#腫瘍学
Tsubata Y, Hotta T, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, Honda R, Senoo T, Nakanishi M, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Ohtsu H, Kobayashi K, Isobe T
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)
Ther Adv Med Oncol. 2022 JUL;14
Journal Impact Factor 2021: 5.485

#医学 #一般医療 #内科学 #症例報告 #レビュー論文
Kuroda H, Yamaguchi A, Sugata S, Hamada T, Moriuchi R, Wada K, Tamaru Y, Kusunoki R, Kuwai T, Kouno H, Kurashige T, Torii T, Saito A, Kuraoka K, Kohno H
Advanced gallbladder cancer accompanied with cancer-associated dermatomyositis: A case report and literature review
Medicine (Baltimore). 2022 JUL 8;101(27)
Journal Impact Factor 2021: 1.817

#消化器病学 #肝臓学
Yamaguchi M, Tashiro H, Kuroda S, Okimoto S, Kobayashi T, Hinoi T, Ohdan H
Downregulation of thrombomodulin contributes to ischemia-reperfusion injury in mice with steatotic liver
Hepatol Res. 2022 SEP;52(9):762-772.
Journal Impact Factor 2021: 4.942

#臨床神経学
Kurashige T, Morino H, Murao T, Izumi Y, Sugiura T, Kuraoka K, Kawakami H, Torii T, Maruyama H
TDP-43 Accumulation Within Intramuscular Nerve Bundles of Patients With Amyotrophic Lateral Sclerosis
JAMA Neurol. 2022 JUL;79(7):693-701.
Journal Impact Factor 2021: 29.907


福山医療センター

#腫瘍学
Yukihiro K, Teishima J, Goto K, Aoki G, Sekino Y, Hayashi T, Hasegawa Y, Mita K, Kato M, Kajiwara M, Shigeta M, Maruyama S, Kadonishi Y, Fujiwara S, Hinata N
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor
Urol Oncol-Semin Orig Investig. 2022 OCT;40(10)
Journal Impact Factor 2021: 2.954


東広島医療センター

#腫瘍学
Yukihiro K, Teishima J, Goto K, Aoki G, Sekino Y, Hayashi T, Hasegawa Y, Mita K, Kato M, Kajiwara M, Shigeta M, Maruyama S, Kadonishi Y, Fujiwara S, Hinata N
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor
Urol Oncol-Semin Orig Investig. 2022 OCT;40(10)
Journal Impact Factor 2021: 2.954

#外科学 #症例報告
Kohata A, Inoue M, Nomimura K, Matsubara K, Kochi M, Hotta R, Miyamoto K, Toyota K, Sadamoto S, Takahashi T
Surgical treatment of hepatic xanthogranuloma arising from a giant hepatic cyst causing gastrointestinal obstruction: a case report
J Surg Case Rep. 2022 JUL 1;2022(7)
Journal Impact Factor 2021: N/A


山口宇部医療センター

#腫瘍学
Tsubata Y, Hotta T, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, Honda R, Senoo T, Nakanishi M, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Ohtsu H, Kobayashi K, Isobe T
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)
Ther Adv Med Oncol. 2022 JUL;14
Journal Impact Factor 2021: 5.485

#腫瘍学
Okita R, Okada M, Inokawa H, Murakami T, Ikeda E
Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy
Surg Oncol-Oxf. 2022 AUG;43
Journal Impact Factor 2021: 2.388


岩国医療センター

#医学 #一般医療 #内科学 #症例報告
Watanabe M, Tanakaya K, Furukawa S, Shiotani T, Sato Y, Taniguchi F, Kanaya N, Aoki H, Sugano K, Ishida H, Akagi K, Kataoka K
Two Cases of Thymic Cancer in Patients with Lynch Syndrome
Intern Med. 2023;62(4):649-653.
Journal Impact Factor 2021: 1.282

#腫瘍学
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Ther Adv Med Oncol. 2022 JUL;14
Journal Impact Factor 2021: 5.485

#腫瘍学
Tsubata Y, Hotta T, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, Honda R, Senoo T, Nakanishi M, Yamasaki M, Ishikawa N, Fujitaka K, Kubota T, Ohtsu H, Kobayashi K, Isobe T
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)
Ther Adv Med Oncol. 2022 JUL;14
Journal Impact Factor 2021: 5.485


東徳島医療センター

#外科学
Sasa S, Inoue H, Inui T, Miyamoto N, Aoyama M, Okumura K, Toba H, Yoshida T, Tezuka M, Hirose C, Saijo Y, Uehara H, Izumori A, Takahashi M, Sasa M, Takizawa H
Axillary lymphangioma that developed following COVID-19 vaccination: a case report
SURG CASE REP. 2022 JUL 8;8(1)
Journal Impact Factor 2021: N/A


四国こどもとおとなの医療センター

#末梢血管疾患 #観察研究 #多施設共同研究
Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo MKT, CLOT-COVID Study Investigators
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study
J Atheroscler Thromb. 2023;30(6):624-635.
Journal Impact Factor 2021: 4.399

#心臓 #循環器系 #多施設共同研究
Ikeda S, Ueno Y, Maemura K, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M, Yamashita Y, CLOT-COVID Study Invest
Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission-From the CLOT-COVID Study
Circ J. 2023 MAR;87(3):448-+.
Journal Impact Factor 2021: 3.35


四国がんセンター

#腫瘍学 #多施設共同研究
Tachibana H, Watanabe Y, Kurokawa S, Maeyama T, Hiroki T, Ikoma H, Hirashima H, Kojima H, Shiinoki T, Tanimoto Y, Shimizu H, Shishido H, Oka Y, Hirose TA, Kinjo M, Morozumi T, Kurooka M, Suzuki H, Saito T, Fujita K, Shirata R, Inada R, Yada R, Yamashita M, Kondo K, Hanada T, Takenaka T, Usui K, Okamoto H, Asakura H, Notake R, Kojima T, Kumazaki Y, Hatanaka S, Kikumura R, Nakajima M, Nakada R, Suzuki R, Mizuno H, Kawamura S, Nakamura M, Akimoto T
Multi-Institutional Study of End-to-End Dose Delivery Quality Assurance Testing for Image-Guided Brachytherapy Using a Gel Dosimeter
Brachytherapy. 2022 NOV-DEC;21(6):956-967.
Journal Impact Factor 2021: 2.441

#消化器病学 #肝臓学 #多施設共同研究
Ohata K, Kobayashi N, Sakai E, Takeuchi Y, Chino A, Takamaru H, Kodashima S, Hotta K, Harada K, Ikematsu H, Uraoka T, Murakami T, Tsuji S, Abe T, Katagiri A, Hori S, Michida T, Suzuki T, Fukuzawa M, Kiriyama S, Fukase K, Murakami Y, Ishikawa H, Saito Y
Long-term Outcomes After Endoscopic Submucosal Dissection for Large Colorectal Epithelial Neoplasms: A Prospective, Multicenter, Cohort Trial From Japan
Gastroenterology. 2022 NOV;163(5):1423-+.
Journal Impact Factor 2021: 33.883

#皮膚病学
Sunaga Y, Hama N, Ochiai H, Kokaze A, Lee ES, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Sueki H
Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients
J Dermatol Sci. 2022 AUG;107(2):75-81.
Journal Impact Factor 2021: 5.408

#腫瘍学
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Grp Clinical Practice Canc, HBOC, Japan Soc Gynecologic Oncology
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
J Gynecol Oncol. 2022 SEP;33(5)
Journal Impact Factor 2021: 4.756

#消化器病学 #肝臓学 #第II相試験 #多施設共同研究
Kojima T, Kato K, Hara H, Takahashi S, Muro K, Nishina T, Wakabayashi M, Nomura S, Sato A, Ohtsu A, Doi T
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303)
Esophagus. 2022 OCT;19(4):702-710.
Journal Impact Factor 2021: 3.671

#腫瘍学 #ランダム化比較試験
Yonemori K, Yunokawa M, Ushijima K, Sakata J, Shikama A, Minobe S, Usami T, Enomoto T, Takehara K, Hasegawa K, Yamagami W, Yamamoto K, Han SR, Dutta L, Orlowski R, Miura T, Makker V, Fujiwara K
Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775
Cancer Sci. 2022 OCT;113(10):3489-3497.
Journal Impact Factor 2021: 6.518

#腫瘍学 #第III相試験 #多施設共同研究 #ランダム化比較試験
Yamamoto Y, Iwata H, Taira N, Masuda N, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Saji S, Morita S, Toi M, Ohno S
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS)
Cancer Sci. 2022 SEP;113(9):3169-3179.
Journal Impact Factor 2021: 6.518

#腫瘍学 #多施設共同研究
Nozaki M, Kagami Y, Takahashi M, Machida R, Sekino Y, Shibata T, Ito Y, Nishimura Y, Teshima T, Ushijima H, Nagata Y, Matsumoto Y, Akimoto T, Takahashi K, Murayama S, Uno T, Tsujino K, Hamamoto Y, Nakagawa K, Kodaira T, Hiraoka M, Radiation Therapy Study Grp, Japan Clinical Oncology Grp
Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906
Breast Cancer. 2022 NOV;29(6):1042-1049.
Journal Impact Factor 2021: 3.307

#泌尿器学 #腎臓学
Kato T, Yokomizo A, Matsumoto R, Tohi Y, Miyakawa J, Mitsuzuka K, Sasaki H, Inokuchi J, Matsumura M, Sakamoto S, Kinoshita H, Fukuhara H, Kamiya N, Kimura R, Nitta M, Okuno H, Akakura K, Kakehi Y, Sugimoto M
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study
Int J Urol. 2022 NOV;29(11):1271-1278.
Journal Impact Factor 2021: 2.896

#腫瘍学 #第II相試験
Yamaguchi K, Minashi K, Sakai D, Nishina T, Omuro Y, Tsuda M, Iwagami S, Kawakami H, Esaki T, Sugimoto N, Oshima T, Kato K, Amagai K, Hosaka H, Komine K, Yasui H, Negoro Y, Ishido K, Tsushima T, Han SR, Shiratori S, Takami T, Shitara K
Phase IIb study of pembrolizumab combined with S-1+oxaliplatin or S-1+cisplatin as first-line chemotherapy for gastric cancer
Cancer Sci. 2022 AUG;113(8):2814-2827.
Journal Impact Factor 2021: 6.518

#腫瘍学 #第II相試験
Moriwaki T, Nishina T, Sakai Y, Yamamoto Y, Shimada M, Ishida H, Amagai K, Sato M, Endo S, Negoro Y, Kuramochi H, Denda T, Hatachi Y, Ikezawa K, Nakajima G, Bando Y, Tsuji A, Yamamoto Y, Morimoto M, Kobayashi K, Hyodo I
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years
Jpn J Clin Oncol. 2022 JUL 8;52(7):717-726.
Journal Impact Factor 2021: 2.925


愛媛医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#腫瘍学 #第II相試験
Moriwaki T, Nishina T, Sakai Y, Yamamoto Y, Shimada M, Ishida H, Amagai K, Sato M, Endo S, Negoro Y, Kuramochi H, Denda T, Hatachi Y, Ikezawa K, Nakajima G, Bando Y, Tsuji A, Yamamoto Y, Morimoto M, Kobayashi K, Hyodo I
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years
Jpn J Clin Oncol. 2022 JUL 8;52(7):717-726.
Journal Impact Factor 2021: 2.925


高知病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#腫瘍学
Takeuchi E, Kondo K, Okano Y, Kunishige M, Kondo Y, Kadota N, Machida H, Hatakeyama N, Naruse K, Ogino H, Nokihara H, Shinohara T, Nishioka Y
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
J Cancer Res Clin Oncol. 2023 JUL;149(7):3139-3147.
Journal Impact Factor 2021: 4.322


小倉医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


九州がんセンター

#腫瘍学 #第II相試験
Tan DSW, Kim SW, Aix SP, Sequist LV, Smit EF, Yang JCH, Hida T, Toyozawa R, Felip E, Wolf J, Grohé C, Leighl NB, Riely G, Cui XM, Zou MK, Ghebremariam S, O'Sullivan-Djentuh L, Belli R, Giovannini M, Kim DW
Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study
Eur J Cancer. 2022 SEP;172:276-286.
Journal Impact Factor 2021: 10.002

#腫瘍学 #第II相試験
Fukuda M, Yamaguchi M, Yamazaki T, Funaki S, Mukae H, Fukuoka J, Nabeshima K, Tateyama H, Ashizawa K, Tomiyama N, Hara M, Seto T, Okumura M, Sugio K
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study
Thorac Cancer. 2022 SEP;13(17):2499-2506.
Journal Impact Factor 2021: 3.223

#複合科学 #多施設共同研究
Wakasaki T, Manako T, Yasumatsu R, Hara H, Toh S, Masuda M, Yamauchi M, Kuratomi Y, Nishimura E, Takeuchi T, Matsuo M, Jiromaru R, Hashimoto K, Komune N, Nakagawa T
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
PLoS One. 2022 JUL 28;17(7)
Journal Impact Factor 2021: 3.752

#腫瘍学 #多施設共同研究 #観察研究
Ito T, Takashima A, Yamazaki K, Yukami H, Uetake H, Tsuda M, Suto T, Moriwaki T, Sugimoto N, Ojima H, Takii Y, Yasui H, Esaki T, Tsuji A, Goto M, Saruta M, Otsu S, Shinozaki K, Fujiwara T, Tamura T, Baba E, Shiozawa M, Denda T, Ueno H, Nagashima K, Shimada Y
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Int J Clin Oncol. 2022 SEP;27(9):1450-1458.
Journal Impact Factor 2021: 3.85

#腫瘍学 #第I相試験 #第II相試験
Ishizawa K, Yokoyama M, Kato H, Yamamoto K, Makita M, Ando K, Ueda Y, Tachikawa Y, Suehiro Y, Kurosawa M, Kameoka Y, Nagai H, Uoshima N, Ishikawa T, Hidaka M, Ito Y, Utsunomiya A, Fukushima K, Ogura M
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
Cancer Chemother Pharmacol. 2022 JUL;90(1):83-95.
Journal Impact Factor 2021: 3.288

#細胞生物学
Tanigawa M, Koga Y, Naito Y, Yamaguchi H, Iwasaki T, Kohashi K, Ohike N, Hanada K, Higashi M, Komatsu M, Imai H, Yamakita K, Nagakawa T, Okabe Y, Kato S, Noguchi H, Nakayama T, Yasuda M, Kusano H, Akiba J, Oda Y, Yano H
Pancreatic hamartoma: detection of harbouring NAB2::STAT6 fusion gene
Histopathology. 2022 SEP;81(3):319-328.
Journal Impact Factor 2021: 7.778

#腫瘍学
Ono Y, Tagawa T, Kinoshita F, Haratake N, Takada K, Kohno M, Takenaka T, Kamitani T, Shimokawa M, Oda Y, Mori M, Yoshizumi T
Relationship between consolidation tumor ratio and tumor-infiltrating lymphocytes in small-sized lung adenocarcinoma
Thorac Cancer. 2022 AUG;13(15):2134-2141.
Journal Impact Factor 2021: 3.223

#腫瘍学 #第II相試験
Yamaguchi K, Minashi K, Sakai D, Nishina T, Omuro Y, Tsuda M, Iwagami S, Kawakami H, Esaki T, Sugimoto N, Oshima T, Kato K, Amagai K, Hosaka H, Komine K, Yasui H, Negoro Y, Ishido K, Tsushima T, Han SR, Shiratori S, Takami T, Shitara K
Phase IIb study of pembrolizumab combined with S-1+oxaliplatin or S-1+cisplatin as first-line chemotherapy for gastric cancer
Cancer Sci. 2022 AUG;113(8):2814-2827.
Journal Impact Factor 2021: 6.518

#医学 #研究 #実験 #観察研究
Matsuo M, Yasumatsu R, Masuda M, Yamauchi M, Wakasaki T, Hashimoto K, Jiromaru R, Manako T, Nakagawa T
Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years
In Vivo. 2022 JUL-AUG;36(4):1881-1886.
Journal Impact Factor 2021: 2.406

#腫瘍学 #第I相試験 #第II相試験
Komoto I, Kokudo N, Aoki T, Morizane C, Ito T, Hashimoto T, Kimura W, Inoue N, Hasegawa K, Kondo S, Ueno H, Igarashi H, Oono T, Makuuchi M, Takamoto T, Hirai I, Takeshita A, Imamura M
Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors
Jpn J Clin Oncol. 2022 JUL 8;52(7):708-716.
Journal Impact Factor 2021: 2.925


九州医療センター

#末梢血管疾患
Tsuda S, Nakayama M, Tanaka S, Haruyama N, Yoshitomi R, Fukui A, Tsuruya K, Nakano T, Kitazono T
The Association of Controlling Nutritional Status Score and Prognostic Nutritional Index with Cardiovascular Diseases: the Fukuoka Kidney Disease Registry Study
J Atheroscler Thromb. 2023;30(4):390-407.
Journal Impact Factor 2021: 4.399

#心臓 #循環器系 #観察研究 #多施設共同研究
Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K, Shimizu W, Suzuki S, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Morishima Y, Takita A, Inoue H
Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation
Circ J. 2023 JAN;87(1):6-+.
Journal Impact Factor 2021: 3.35

#臨床神経学
Tokunaga K, Tokunaga S, Hara K, Yasaka M, Okada Y, Kitazono T, Tsumoto T
Fluid-attenuated inversion recovery vascular hyperintensity-diffusion-weighted imaging mismatch and functional outcome after endovascular reperfusion therapy for acute ischemic stroke
Interv Neuroradiol. 2022 JUL 29;
Journal Impact Factor 2021: 1.764

#医学 #一般医療 #内科学
Miyamatsu Y, Nakamizo A, Amano T, Matsuo S, Kuwashiro T, Yasaka M, Okada Y, Mizoguchi M, Yoshimoto K
Ankle-Brachial Index and Cardio-Ankle Vascular Index as Predictors of Cognitive Decline Over Time After Carotid Endarterectomy
Cureus J Med Sci. 2022 JUL 3;14(7)
Journal Impact Factor 2021: N/A

#外科学 #観察研究
Minoda Y, Ihara E, Itaba S, Sumida Y, Haraguchi K, Aso A, Mizutani T, Osoegawa T, Esaki M, Nagatomo S, Nishioka K, Muta K, Bai XP, Ogino H, Fujimori N, Tsurumaru D, Ohuchida K, Qingjiang H, Oki E, Yamamoto H, Ogawa Y
Negligible procedure-related dissemination risk of mucosal incision-assisted biopsy for gastrointestinal stromal tumors versus endoscopic ultrasound-guided fine-needle aspiration/biopsy
Surg Endosc. 2023 JAN;37(1):101-108.
Journal Impact Factor 2021: 3.453

#薬理学 #薬学
Teramoto T, Ogawa H, Ueshima H, Okada Y, Haze K, Matsui S, Fujikawa K, Hashimoto T, Sakui S, Nishimura K, Kajita M, Horimoto A, Fernandez J
Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey)
Expert Opin Drug Saf. 2023 JAN 2;22(1):81-90.
Journal Impact Factor 2021: 4.011

#腫瘍学
Ono Y, Tagawa T, Kinoshita F, Haratake N, Takada K, Kohno M, Takenaka T, Kamitani T, Shimokawa M, Oda Y, Mori M, Yoshizumi T
Relationship between consolidation tumor ratio and tumor-infiltrating lymphocytes in small-sized lung adenocarcinoma
Thorac Cancer. 2022 AUG;13(15):2134-2141.
Journal Impact Factor 2021: 3.223


福岡病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#複合科学
Yoshida M, Hiramoto T, Moriwaki A, Osoreda H, Iwanaga T, Inoue H
Impact of extrapulmonary comorbidities on physical activity in chronic obstructive pulmonary disease in Japan: A cross-sectional study
PLoS One. 2022 JUL 27;17(7)
Journal Impact Factor 2021: 3.752


大牟田病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#腫瘍学
Ikematsu Y, Izumi M, Takayama K, Kumazoe H, Wakamatsu K, Kawasaki M
Small-cell lung cancer from the peripheral lung is frequently accompanied by emphysema and interstitial lung disease in the background
Thorac Cancer. 2022 SEP;13(18):2616-2623.
Journal Impact Factor 2021: 3.223


福岡東医療センター

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478


佐賀病院

#産科学 #婦人科学
Tsuda S, Shinagawa T, Tsumura K, So KN, Yamasaki F, Kawaguchi A, Nakura Y, Yanagihara I, Nomiyama M, Yokoyama M
Estimated time to emergence of secondary intra-amniotic infection or inflammation since the onset of the preterm premature rupture of membranes
Taiwan J Obstet Gynecol. 2022 JUL;61(4):634-640.
Journal Impact Factor 2021: 1.944


嬉野医療センター

#呼吸器系
Zaits M, Morita S
Infants Hospitalized with Lower Respiratory Tract Infections Were More Likely to Develop Asthma
Adv Respir Med. 2022 AUG;90(4):246-253.
Journal Impact Factor 2021: N/A

#腫瘍学 #プロトコル論文
Akagi K, Taniguchi H, Fukuda M, Yamazaki T, Ono S, Tomono H, Suyama T, Shimada M, Gyotoku H, Takemoto S, Yamaguchi H, Dotsu Y, Senju H, Soda H, Mizowaki T, Monzen Y, Ikeda T, Nagashima S, Tasaki Y, Nakamura D, Komiya K, Nakatomi K, Sasaki E, Hirakawa K, Mukae H
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study
Thorac Cancer. 2022 AUG;13(16):2404-2409.
Journal Impact Factor 2021: 3.223


長崎病院

#血液学 #観察研究
Lin YW, Oji S, Miyamoto K, Narita T, Kameyama M, Matsuo H
Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study
Ther Apher Dial. 2023 FEB;27(1):123-135.
Journal Impact Factor 2021: 2.195


長崎医療センター

#皮膚病学 #観察研究
Takazono T, Hidaka Y, Morimoto S, Tashiro M, Ashizawa N, Hirayama T, Takeda K, Iwanaga N, Hosogaya N, Yamamoto K, Fushimi K, Yanagihara K, Mukae H, Izumikawa K
Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non-HIV Cryptococcal meningitis: A nationwide observational study
Mycoses. 2022 SEP;65(9):897-902.
Journal Impact Factor 2021: 4.931

#消化器病学 #肝臓学
Kimura M, Nishikawa K, Osawa Y, Imamura J, Yamaji K, Harada K, Yatsuhashi H, Murata K, Miura K, Tanaka A, Kanto T, Kohara M, Kamisawa T, Kimura K
Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease
Hepatol Commun. 2022 OCT;6(10):2732-2747.
Journal Impact Factor 2021: 5.701

#看護
Suzuki M, Harada N, Honda K, Koda M, Araki T, Kudo T, Watanabe T
Facilitators and barriers in implementing the nurse practitioner role in Japan: A cross-sectional descriptive study
Int Nurs Rev. 2022 JUL 15;
Journal Impact Factor 2021: 3.384

#腫瘍学 #プロトコル論文
Akagi K, Taniguchi H, Fukuda M, Yamazaki T, Ono S, Tomono H, Suyama T, Shimada M, Gyotoku H, Takemoto S, Yamaguchi H, Dotsu Y, Senju H, Soda H, Mizowaki T, Monzen Y, Ikeda T, Nagashima S, Tasaki Y, Nakamura D, Komiya K, Nakatomi K, Sasaki E, Hirakawa K, Mukae H
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study
Thorac Cancer. 2022 AUG;13(16):2404-2409.
Journal Impact Factor 2021: 3.223

#臨床神経学
Hamasaki T, Uchikawa H, Ohmori Y, Kaku Y, Ono T, Tochihara S, Hirai T, Kawano T, Mukasa A
Variations in the branching patterns of the anterior choroidal artery: an angiographic study with special reference to temporal lobe epilepsy surgery
Acta Neurochir. 2022 AUG;164(8):2165-2172.
Journal Impact Factor 2021: 2.816


長崎川棚医療センター

#血液学 #観察研究
Lin YW, Oji S, Miyamoto K, Narita T, Kameyama M, Matsuo H
Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study
Ther Apher Dial. 2023 FEB;27(1):123-135.
Journal Impact Factor 2021: 2.195

#臨床神経学
Tanaka K, Nagaishi A, Matsui M
Autoimmunity to ion channels in neurological diseases-Autoimmunity to aquaporin water channels
Neurol Clin Neurosci. 2022 JUL 7;
Journal Impact Factor 2021: N/A


熊本医療センター

#内分泌学 #新陳代謝 #多施設共同研究
Shirahama Y, Tabata N, Sakamoto K, Sato R, Yamanaga K, Fujisue K, Sueta D, Araki S, Takashio S, Arima Y, Hokimoto S, Sato K, Sakamoto T, Nakao K, Shimomura H, Matsumura T, Tayama S, Fujimoto K, Oshima S, Nakamura S, Tsunoda R, Hirose T, Kikuta K, Sakaino N, Yamamoto N, Kajiwara I, Suzuki S, Yamamoto E, Kaikita K, Matsushita K, Tsujita K, Kumamoto Intervention Conf Study K
Validation of the obesity paradox by body mass index and waist circumference in patients undergoing percutaneous coronary intervention
Int J Obes. 2022 OCT;46(10):1840-1848.
Journal Impact Factor 2021: 5.551

#腫瘍学 #第I相試験 #第II相試験
Ishizawa K, Yokoyama M, Kato H, Yamamoto K, Makita M, Ando K, Ueda Y, Tachikawa Y, Suehiro Y, Kurosawa M, Kameoka Y, Nagai H, Uoshima N, Ishikawa T, Hidaka M, Ito Y, Utsunomiya A, Fukushima K, Ogura M
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
Cancer Chemother Pharmacol. 2022 JUL;90(1):83-95.
Journal Impact Factor 2021: 3.288

#腫瘍学
Morita-Fujita M, Arai Y, Kondo T, Harada K, Uchida N, Toya T, Ozawa Y, Fukuda T, Ota S, Onizuka M, Kanda Y, Maruyama Y, Takada S, Kawakita T, Ara T, Ichinohe T, Kimura T, Atsuta Y, Kako S
Adult patients with Ph plus ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI
Hematol Oncol. 2022 DEC;40(5):1041-1055.
Journal Impact Factor 2021: 4.85


宮崎東病院

#内分泌学 #新陳代謝
Matsuyama M, Sawada H, Inoue S, Hishinuma A, Sekiya R, Sato Y, Moritake H
Goiter in a 6-year-old patient with novel thyroglobulin gene variant (Gly145Glu) causing intracellular thyroglobulin transport disorder: Correlation between goiter size and the free T3 to free T4 ratio
Clin Pediatr Endocrinol. 2022 JUL;31(3):185-191.
Journal Impact Factor 2021: N/A


鹿児島医療センター

#医学 #一般医療 #内科学 #症例報告
Hamada Y, Shigehisa A, Kanda Y, Ikeda M, Takaguchi G, Matsuoka H, Takashima H
Enhancement of the Ivy Sign during an Ischemic Event in Moyamoya Disease
Intern Med. 2023;62(4):617-621.
Journal Impact Factor 2021: 1.282

#皮膚病学
Goto K, Ogawa K, Hishima T, Oishi N, Tomita O, Tsuyuki T, Oda T, Iwahashi Y, Inaba Y, Honma K
Seborrheic Keratosis With Malignant Transformation (Invasive or Noninvasive Squamous Cell Carcinoma Arising in Seborrheic Keratosis): A Clinicopathologic and Immunohistochemical Study of 11 Cases
Am J Dermatopathol. 2022 DEC;44(12):891-899.
Journal Impact Factor 2021: 1.319

#皮膚病学 #症例報告
Bun S, Goto K, Oishi T, Kiyohara Y, Tsutsumida A, Yoshikawa S
Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum
Am J Dermatopathol. 2022 NOV;44(11):850-854.
Journal Impact Factor 2021: 1.319


沖縄病院

#アレルギー
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)
Allergol Int. 2023 JAN;72(1):63-74.
Journal Impact Factor 2021: 7.478

#感染症
Miyashita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Kiyota H, Watanabe A
Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to legionella pneumonia
J Infect Chemother. 2022 OCT;28(10):1353-1357.
Journal Impact Factor 2021: 2.065


登録日: 2023年2月10日 / 更新日: 2024年1月31日

  • ページの先頭
  • 戻る
  • このページを印刷する -